Chia‐Lun Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chia‐Lun Li has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Sheng‐Hsiang Ma
Department of Dermatology Taipei Veterans General Hospital Taipei Taiwan
2 shared publications C-Y Wu
Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
1 shared publicationC-Yi Wu
Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan
1 shared publicationChen‐Yi Wu
Department of Dermatology Taipei Veterans General Hospital Taipei Taiwan
1 shared publicationP-H Chang
Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan
1 shared publicationY-T Chang
Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan
1 shared publication
Latest Publications
- 31 August 2023
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 26 (12) , 2583-2584
Anti‐TIF1‐γ antibody‐positive dermatomyositis
- 31 August 2023
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 26 (12) , 2583-2584
Anti‐TIF1‐γ antibody‐positive dermatomyositis
- 19 March 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (7) , 1097-1103
Association between sensorineural hearing loss and vitiligo: a nationwide population‐based cohort study
Background: Vitiligo is an acquired depigmentation disease of the skin due to melanocyte destruction. A shared pathogenesis affecting melanocytes in the cochlea has been postulated. However, the association between vitiligo and sensorineural hearing loss (SNHL) is unclear.Objective: To identify the association between vitiligo and SNHL.Methods: This retrospective, nationwide cohort study included patients with vitiligo and age‐, sex‐ and comorbidities‐matched controls (propensity score matching; 1:4 ratio) from the National Health Insurance Research Database in Taiwan from 1 January 2000 to 31 December 2013.Results: In total, 13 048 patients with vitiligo and 52 192 controls were included. SNHL developed in 0.61% patients with vitiligo and 0.29% controls. After adjusting for sex, age and comorbidities, a significant association between vitiligo and SNHL was found (adjusted hazard ratio, 2.18; 95% CI, 1.66–2.86). The other risk factors for developing SNHL included increased age, male sex, hyperlipidaemia, coronary artery disease and diffuse connective tissue diseases. In subgroup analysis, the association between vitiligo and SNHL remained significant in almost all the subgroups.Conclusion: A 2.2‐fold increased risk of developing SNHL was found in patients with vitiligo. Proper referral to otologists for early screening and closer follow‐up of SNHL should be considered for patients with vitiligo, especially for patients with older age.
- 19 March 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (7) , 1097-1103
Association between sensorineural hearing loss and vitiligo: a nationwide population‐based cohort study
Background: Vitiligo is an acquired depigmentation disease of the skin due to melanocyte destruction. A shared pathogenesis affecting melanocytes in the cochlea has been postulated. However, the association between vitiligo and sensorineural hearing loss (SNHL) is unclear.Objective: To identify the association between vitiligo and SNHL.Methods: This retrospective, nationwide cohort study included patients with vitiligo and age‐, sex‐ and comorbidities‐matched controls (propensity score matching; 1:4 ratio) from the National Health Insurance Research Database in Taiwan from 1 January 2000 to 31 December 2013.Results: In total, 13 048 patients with vitiligo and 52 192 controls were included. SNHL developed in 0.61% patients with vitiligo and 0.29% controls. After adjusting for sex, age and comorbidities, a significant association between vitiligo and SNHL was found (adjusted hazard ratio, 2.18; 95% CI, 1.66–2.86). The other risk factors for developing SNHL included increased age, male sex, hyperlipidaemia, coronary artery disease and diffuse connective tissue diseases. In subgroup analysis, the association between vitiligo and SNHL remained significant in almost all the subgroups.Conclusion: A 2.2‐fold increased risk of developing SNHL was found in patients with vitiligo. Proper referral to otologists for early screening and closer follow‐up of SNHL should be considered for patients with vitiligo, especially for patients with older age.